ArticleTherapeutic advances in rare disease

A novel therapy for pyridoxine-dependent epilepsy due to biallelic pathogenic variants in

Anastasia Ambrose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.